288 related articles for article (PubMed ID: 27708239)
1. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
[TBL] [Abstract][Full Text] [Related]
3. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE
Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368
[TBL] [Abstract][Full Text] [Related]
4. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Gruvberger-Saal SK; Saal LH; Holm K; Hegardt C; Arason A; Fagerholm R; Persson C; Grabau D; Johnsson E; Lövgren K; Magnusson L; Heikkilä P; Agnarsson BA; Johannsson OT; Malmström P; Fernö M; Olsson H; Loman N; Nevanlinna H; Barkardottir RB; Borg Å
Cancer Res; 2012 Aug; 72(16):4028-36. PubMed ID: 22706203
[TBL] [Abstract][Full Text] [Related]
5. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.
Wang J; Ray PS; Sim MS; Zhou XZ; Lu KP; Lee AV; Lin X; Bagaria SP; Giuliano AE; Cui X
Oncogene; 2012 Nov; 31(45):4798-802. PubMed ID: 22249250
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.
Tkocz D; Crawford NT; Buckley NE; Berry FB; Kennedy RD; Gorski JJ; Harkin DP; Mullan PB
Oncogene; 2012 Aug; 31(32):3667-78. PubMed ID: 22120723
[TBL] [Abstract][Full Text] [Related]
7. Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.
Yan M; Shield-Artin K; Byrne D; Deb S; Waddell N; ; Haviv I; Fox SB
BMC Cancer; 2015 Jul; 15():506. PubMed ID: 26152113
[TBL] [Abstract][Full Text] [Related]
8. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer.
Mott L; Su K; Pack DW
Cancer Gene Ther; 2018 May; 25(3-4):84-91. PubMed ID: 29511313
[TBL] [Abstract][Full Text] [Related]
10. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.
Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473
[TBL] [Abstract][Full Text] [Related]
11. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.
Ray PS; Wang J; Qu Y; Sim MS; Shamonki J; Bagaria SP; Ye X; Liu B; Elashoff D; Hoon DS; Walter MA; Martens JW; Richardson AL; Giuliano AE; Cui X
Cancer Res; 2010 May; 70(10):3870-6. PubMed ID: 20406990
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.
Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P
Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208
[TBL] [Abstract][Full Text] [Related]
13. FOXC1: an emerging marker and therapeutic target for cancer.
Han B; Bhowmick N; Qu Y; Chung S; Giuliano AE; Cui X
Oncogene; 2017 Jul; 36(28):3957-3963. PubMed ID: 28288141
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.
Pinilla SM; Honrado E; Hardisson D; Benítez J; Palacios J
Breast Cancer Res Treat; 2006 Sep; 99(1):85-90. PubMed ID: 16541313
[TBL] [Abstract][Full Text] [Related]
15. The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging.
Zuo H; Yang Q
J BUON; 2018; 23(3):720-728. PubMed ID: 30003742
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women.
Jing MX; Mao XY; Li C; Wei J; Liu C; Jin F
Tumour Biol; 2011 Aug; 32(4):713-9. PubMed ID: 21625942
[TBL] [Abstract][Full Text] [Related]
17. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.
Rakha EA; Elsheikh SE; Aleskandarany MA; Habashi HO; Green AR; Powe DG; El-Sayed ME; Benhasouna A; Brunet JS; Akslen LA; Evans AJ; Blamey R; Reis-Filho JS; Foulkes WD; Ellis IO
Clin Cancer Res; 2009 Apr; 15(7):2302-10. PubMed ID: 19318481
[TBL] [Abstract][Full Text] [Related]
18. The role and the potential regulatory pathways of high expression of forkhead box C1 in promoting tumor growth and metastasis of basal-like breast cancer.
Zuo HD; Wu Yao W
J BUON; 2016; 21(4):818-825. PubMed ID: 27685901
[TBL] [Abstract][Full Text] [Related]
19. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.
Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X
Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579
[TBL] [Abstract][Full Text] [Related]
20. p16INK4a expression in basal-like breast carcinoma.
Bohn OL; Fuertes-Camilo M; Navarro L; Saldivar J; Sanchez-Sosa S
Int J Clin Exp Pathol; 2010 Jun; 3(6):600-7. PubMed ID: 20661408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
